Novo Zhiyuan (688315): The growth rate is gradually returning to overseas scale
Novo Zhiyuan (688315): Maintaining rapid growth overseas is expected to return to a healthy track
Novo Zhiyuan (688315): Domestic operations are under pressure, overseas revenue is rising steadily
Novo Zhiyuan (688315): Global localization strategy steadily promotes steady overseas business performance
Novo Zhiyuan (688315): Performance falls short of expectations and shows a quarterly recovery trend and continues to advance the global localization strategy
Novo Zhiyuan (688315) Annual Report Review Report: Steady, Moderate and Better Global Service Capabilities Continue to Improve
Novo Zhiyuan (688315): Business performance is affected by the pace of platform renewal and expansion, short-term pressure is under pressure, and global localization continues to deepen
Novo Zhiyuan (688315): Performance is under pressure due to platform changes, profit margins declined slightly
Novo Zhiyuan (688315): Profitability is under pressure, and the company's net interest rate declined slightly in the third quarter
Novo Zhiyuan (688315): Implementing fixed increases to help long-term development systems iterative cost adjustments
Novo Zhiyuan (688315) Investment Value Analysis Report: Leading Scientific Research and Sequencing Service “Technology+Service” to Build a Comprehensive Moat
Novo Zhiyuan (688315): Sequencing platform switching affects short-term performance and is expected to resume normal growth in Q4
Novo Zhiyuan (688315) Third Quarterly Review Report: Platform Replacement Nurtures High Future Growth
Novo Zhiyuan (688315): The deployment of the new platform has almost been completed, and Q4 is expected to return to a healthy growth trajectory
Novo Zhiyuan (688315): Platform changes affect short-term performance and implementation are expected to further deepen the global layout
Novo Zhiyuan (688315): The third quarter results were under short-term pressure, fixed increases, capital raised, and the company's long-term development can be expected
Novo Zhiyuan (688315): Q3 performance is under pressure and sequencing platform switching is expected to have a phased impact
Nowha Zhiyuan (688315): Short-term income fluctuations can still be expected throughout the year
Novo Zhiyuan (688315): Platform switching affects short-term business pace, optimistic about long-term growth of core business
Research Report Nuggets | Guosheng Securities: Novell's Globalization Strategy Promotes Results, Maintains “Buy” Rating
No Data